jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Article

Pharma 4.0: Enhancing Process Robustness in Pharmaceutical Manufacturing through Industry 4.0 Integration

Rajesh Balam1, Priyanka Mahesh1, Kinjal Gandhi2, Swathi Ganesha Poojary1, Ajith Chandran3, Anoop Narayanan Vadakkepushpakath3★★ Corresponding author

  1. 1NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Quality Assurance, Deralakatte, Mangalore, Karnataka, INDIA.
  2. 2Professor, Department of Pharmaceutics, Chemist College of Pharmaceutical Science and Research, Ernakulam, Kerala, INDIA.
  3. 3NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Deralakatte, Mangalore, Karnataka, INDIA.

CORRESPONDENCE

Anoop Narayanan Vadakkepushpakath

NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Deralakatte, Mangalore, Karnataka, INDIA.

anoopvn84@gmail.com

Received: 14-05-2025; Revised: 04-07-2025; Accepted: 29-09-2025.

Volume 17, Issue 4 · pp. 784–789 · PUBLISHED · DOI: 10.5530/jyp.20250104

View on JYP original site ↗

ABSTRACT

The pharmaceutical industry is currently welcoming a digital revolution known as Pharma 4.0, which builds upon the principles of Industry 4.0 to improve product quality, operational efficiency, and compliance. This transformation uses state-of-the-art technologies like the Internet of Things (IoT), AI, big data analytics, and blockchain to create smarter, more flexible manufacturing processes. This review explores how Pharma 4.0 tools help strengthen process reliability in pharmaceutical production. It examines how digital integration influences Critical Quality Attributes (CQAs), ensures regulatory compliance, and boosts overall operational effectiveness. A thorough review of existing literature, including peer-reviewed articles, regulatory guidance, and practical case studies related to Pharma 4.0, was conducted. The focus is on digital solutions that monitor Critical Process Parameters (CPPs), use predictive analytics, and support frameworks like Quality by Design (QbD) and Process Analytical Technology (PAT). Incorporating smart technologies enhances process consistency, reduces human error, and allows for real-time quality oversight. Utilizing robotic automation and intelligent sensors improves data collection and assists adaptive feedback loops. Real-world case studies emphasize successful deployments of Pharma 4.0 tools in areas like predictive maintenance, real-time process monitoring, and regulatory compliance, resulting in less variability and more reliable products. Eventually, Pharma 4.0 represents a major shift in pharmaceutical manufacturing, helping to make processes more resilient and supporting data-driven decision-making. However, its success depends on regulatory adjustments, collaboration across disciplines, and addressing challenges around data integrity and system validation.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Balam, R., Mahesh, P., Gandhi, K., Poojary, S. G., Chandran, A., & Vadakkepushpakath, A. N. (). Pharma 4.0: Enhancing Process Robustness in Pharmaceutical Manufacturing through Industry 4.0 Integration. Journal of Young Pharmacists, 17(4), 784–789. https://doi.org/10.5530/jyp.20250104